Azathioprine
Azathioprine is a pharmaceutical drug with 91 clinical trials. Currently 13 active trials ongoing. Historical success rate of 70.2%.
Success Metrics
Based on 40 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
19
Mid Stage
52
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
67.8%
40 of 59 finished
32.2%
19 ended early
13
trials recruiting
91
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Disease-Modifying Treatments for Myasthenia Gravis
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Clinical Trials (91)
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Disease-Modifying Treatments for Myasthenia Gravis
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial
A Randomized Multicenter Study for Isolated Skin Vasculitis
Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
Efficacy Study of Two Treatments in the Remission of Vasculitis
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo
Post-Operative Crohn's Disease Outcome in Children
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Beneficial Effect of Silymarin in Ulcerative Colitis
Azathioprine in MOGAD
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 91